MedPath

AI-ECG Accessory Pathway Localisation Study

Not yet recruiting
Conditions
Accessory Pathway
Artifical Intelligence
ECG
Registration Number
NCT07083791
Lead Sponsor
Imperial College London
Brief Summary

This study seeks to validate the real-world accuracy of an AI-based algorithm for identifying the location of an accessory pathway from the 12-lead electrocardiogram

Detailed Description

Silent validation study of an AI-ECG (artificial intelligence applied to electrocardiography) accessory pathway localisation algorithm, applied to prospective and consecutive cases in clinical practice, to determine its true accuracy and performance.

A pre-existing AI-ECG algorithm will be applied to participant ECG data, collected at the time of their clinical electrophysiology study (EPS) for ablation of their accessory pathway. This will be compared to the ground truth of the successful ablation location, determined by fluoroscopy and/or 3D electroanatomical mapping from their procedure.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Referred for EPS procedure as part of their clinical care, with a finding of pre-excitation on their ECG
  • Manifest pre-excitation on their ECG any time prior to their procedure
  • Able to give consent
  • Minimum age 13 years old
  • Maximum age 100 years old
Exclusion Criteria
  • Unable to give consent
  • Adults > 100 years old
  • Children < 13 years old
  • Patients with known location of their accessory pathway from a previous EP study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Performance and accuracy of the AI-ECG accessory pathway localisation algorithmAt completion of recruitment, anticipated at 18 months

Performance metrics of the AI-ECG accessory pathway localisation algorithm, including accuracy, F1-score, sensitivity, specificity, positive and negative predictive values. Benchmarked against the ground truth of human operator assessment from fluoroscopy and/or 3D electroanatomical mapping.

Secondary Outcome Measures
NameTimeMethod
Accuracy of the ground truth locations from the human operator compared to the successful ablation locationAt completion of recruitment, anticipated at 18 months

The ground truth of successful ablation location determined by operator assessment of fluoroscopy ± 3D mapping will be compared to the true ablation location on a complete 3D electroanatomical annular map

Relative performance of the AI-ECG algorithm compared to human estimationAt completion of recruitment, anticipated at 18 months

Difference in performance/accuracy between the AI-ECG accessory pathway localisation algorithm and human estimation from the 12-lead ECG

Relative performance of the AI-ECG algorithm compared to manual localisation algorithmsAt completion of recruitment, anticipated at 18 months

Difference in performance/accuracy between the AI algorithm and pre-specified, established manual localisation algorithms (Arruda, Milstein, Pambrun, Boersma, D'Avila and Chiang)

Trial Locations

Locations (1)

Imperial College Healthcare NHS Trust

🇬🇧

London, United Kingdom

Imperial College Healthcare NHS Trust
🇬🇧London, United Kingdom
Keenan Saleh, MBBS
Contact
02033132243
k.saleh@nhs.net
Ahran Arnold, PhD
Principal Investigator
Zachary Whinnett, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.